ATE527385T1 - Mit tumoren assoziierte genetische variationen - Google Patents
Mit tumoren assoziierte genetische variationenInfo
- Publication number
- ATE527385T1 ATE527385T1 AT07871494T AT07871494T ATE527385T1 AT E527385 T1 ATE527385 T1 AT E527385T1 AT 07871494 T AT07871494 T AT 07871494T AT 07871494 T AT07871494 T AT 07871494T AT E527385 T1 ATE527385 T1 AT E527385T1
- Authority
- AT
- Austria
- Prior art keywords
- tumors
- variations associated
- genetic variations
- diagnosing
- nucleotide
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 230000002068 genetic effect Effects 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86610306P | 2006-11-16 | 2006-11-16 | |
| US94881807P | 2007-07-10 | 2007-07-10 | |
| PCT/US2007/084888 WO2008061213A2 (en) | 2006-11-16 | 2007-11-15 | Genetic variations associated with tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE527385T1 true ATE527385T1 (de) | 2011-10-15 |
Family
ID=39402492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07871494T ATE527385T1 (de) | 2006-11-16 | 2007-11-15 | Mit tumoren assoziierte genetische variationen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100092965A1 (de) |
| EP (1) | EP2082064B1 (de) |
| JP (1) | JP2010509922A (de) |
| AT (1) | ATE527385T1 (de) |
| AU (1) | AU2007319214B2 (de) |
| CA (1) | CA2667851A1 (de) |
| ES (1) | ES2374954T3 (de) |
| WO (1) | WO2008061213A2 (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| WO2010030865A2 (en) * | 2008-09-11 | 2010-03-18 | The Regents Of The University Of California | Loss of fbxw7 is a biomarker of sensitivity to treatment of tumors with inhibitors of mtor |
| KR102428795B1 (ko) | 2008-11-12 | 2022-08-04 | 인리젠 | 분리된 신장 세포 및 이의 용도 |
| US8320346B2 (en) * | 2009-09-25 | 2012-11-27 | Intel Corporation | Apparatus and methods for universal services interface networking |
| ES2906750T3 (es) | 2010-05-12 | 2022-04-20 | Prokidney | Células renales bioactivas |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US20240158855A1 (en) | 2010-05-18 | 2024-05-16 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| EP2854058A3 (de) | 2010-05-18 | 2015-10-28 | Natera, Inc. | Verfahren zur nichtinvasiven pränatalen Ploidiezuordnung |
| US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12655483B2 (en) | 2010-05-18 | 2026-06-16 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US12545960B2 (en) | 2010-05-18 | 2026-02-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| AU2011348100B2 (en) | 2010-12-22 | 2016-08-25 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| JP6153874B2 (ja) | 2011-02-09 | 2017-06-28 | ナテラ， インコーポレイテッド | 非侵襲的出生前倍数性呼び出しのための方法 |
| AU2012346540C1 (en) * | 2011-11-30 | 2019-07-04 | Genentech, Inc. | ErbB3 mutations in cancer |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| US20170044621A1 (en) * | 2014-04-18 | 2017-02-16 | Blueprint Medicines Corporation | Met fusions |
| US12492429B2 (en) | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| RU2717641C2 (ru) | 2014-04-21 | 2020-03-24 | Натера, Инк. | Обнаружение мутаций и плоидности в хромосомных сегментах |
| US20180173845A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| EP4428863A3 (de) | 2015-05-11 | 2024-12-11 | Natera, Inc. | Verfahren und zusammensetzungen zur bestimmung der ploidie |
| JP7280044B2 (ja) | 2016-04-15 | 2023-05-23 | ナテラ， インコーポレイテッド | 肺癌の検出方法 |
| US11123372B2 (en) | 2016-07-29 | 2021-09-21 | Prokidney | Bioactive renal cells for the treatment of chronic kidney disease |
| WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| WO2019118926A1 (en) | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
| EP3737773B1 (de) | 2018-01-12 | 2023-04-12 | Natera, Inc. | Neuartige primer und verwendungen davon |
| DK3781714T3 (da) | 2018-04-14 | 2026-03-30 | Natera Inc | Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| US12305235B2 (en) | 2019-06-06 | 2025-05-20 | Natera, Inc. | Methods for detecting immune cell DNA and monitoring immune system |
| EP4217376A4 (de) | 2020-09-24 | 2024-10-09 | University of Massachusetts | Für nf1 codierende aav-vektoren und verwendungen davon |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE431417T1 (de) * | 2001-06-14 | 2009-05-15 | Univ California | Mutationen in der mit der resistenz gegenüber sti-571 assoziierten bcr-abl-tyrosinkinase |
| WO2005026329A2 (en) * | 2003-09-12 | 2005-03-24 | Cornell Research Foundation, Inc. | Methods for identifying target nucleic acid molecules |
| US20050142585A1 (en) * | 2003-10-02 | 2005-06-30 | University Of South Florida | Determination of phenotype of cancer and of precancerous tissue |
| AU2005267148A1 (en) * | 2004-07-01 | 2006-02-02 | University Of Southern California | Genetic markers for predicting disease and treatment outcome |
| WO2007109515A2 (en) * | 2006-03-20 | 2007-09-27 | Novartis Ag | Mutations and polymorphisms of knockdown resistance polypeptide |
-
2007
- 2007-11-15 US US12/514,053 patent/US20100092965A1/en not_active Abandoned
- 2007-11-15 WO PCT/US2007/084888 patent/WO2008061213A2/en not_active Ceased
- 2007-11-15 CA CA002667851A patent/CA2667851A1/en not_active Abandoned
- 2007-11-15 EP EP07871494A patent/EP2082064B1/de active Active
- 2007-11-15 AU AU2007319214A patent/AU2007319214B2/en active Active
- 2007-11-15 JP JP2009537379A patent/JP2010509922A/ja active Pending
- 2007-11-15 ES ES07871494T patent/ES2374954T3/es active Active
- 2007-11-15 AT AT07871494T patent/ATE527385T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007319214B2 (en) | 2014-04-17 |
| EP2082064A2 (de) | 2009-07-29 |
| EP2082064B1 (de) | 2011-10-05 |
| WO2008061213A3 (en) | 2008-12-18 |
| CA2667851A1 (en) | 2008-05-22 |
| AU2007319214A1 (en) | 2008-05-22 |
| WO2008061213A2 (en) | 2008-05-22 |
| US20100092965A1 (en) | 2010-04-15 |
| ES2374954T3 (es) | 2012-02-23 |
| JP2010509922A (ja) | 2010-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008061213A3 (en) | Genetic variations associated with tumors | |
| WO2010045318A3 (en) | Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type | |
| BRPI0912927A2 (pt) | "método de detectar um tumor independente de vegf em um indivíduo e método de tratar um tumor independente de vegf em um indivíduo" | |
| MX378733B (es) | Métodos in vitro y composiciones para identificar y usarse en el tratamiento de lupus. | |
| EP2318088A4 (de) | Tragbare anordnungen, systeme und verfahren zur bereitstellung funktioneller oder therapeutischer neurostimulation | |
| WO2008117314A3 (en) | Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
| MX2009004522A (es) | Variantes de suceptibilidad a cancer en chr8q24.21. | |
| WO2009100188A3 (en) | Methods for detection of corn event das-59132 | |
| EA200702203A1 (ru) | Способы и нуклеиновые кислоты для анализов клеточных пролиферативных нарушений | |
| DE602007003165D1 (de) | Verfahren und Systeme zur Definition, Identifikation und Erfassung geometrischer Eigenschaften | |
| BRPI0906237A2 (pt) | manipulação de sistema de informação de célula e tempo especifico para entrega em utra evoluido. | |
| ATE542903T1 (de) | Luciferase-biosensoren für camp | |
| WO2010062960A3 (en) | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE | |
| WO2010062913A3 (en) | Methods and systems for analysis of sequencing data | |
| EA200970695A1 (ru) | Способы и нуклеиновые кислоты для анализов нарушений клеточной пролиферации | |
| WO2008011519A3 (en) | Amigo-2 inhibitors for treating, diagnosing or detecting cancer | |
| DK2024747T3 (da) | Anvendelse af protein SATB2 som prognotisk markør for colerectal cancer | |
| ATE533838T1 (de) | Verfahren zur verbesserten einführung von dna in bakterienzellen | |
| MX2009004382A (es) | Variaciones geneticas asociadas con tumores. | |
| DE602008006254D1 (de) | Doppel-oligonukleotid-nukleinsäurenachweisverfahren | |
| DK2179035T3 (da) | Modificeret bakteriofag omfattende et alfa/beta-sasp-(small acid-soluble spore protein)-gen | |
| CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
| MX2009005058A (es) | Metodos para tratar, diagnosticar o detectar cancer. | |
| ZA200808669B (en) | Methods of treating, diagnosing or detecting cancer | |
| WO2009085196A8 (en) | Methods and compositions for correlating genetic markers with prostate cancer risk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2082064 Country of ref document: EP |